A Combined Phase 0/2 "Trigger" Trial Evaluating Pamiparib or Olaparib with Concurrent Radiotherapy in Patients with Newly-Diagnosed or Recurrent Glioblastoma

Autor: Kennedy, W.R., Chang, Y.W., Jiang, J., Molloy, J., Pennington-Krygier, C., Harmon, J., Hong, A., Wanebo, J., Braun, K., Garcia, M.A., Barani Jr, I.J., Yoo, W., Tovmasyan, A., Tien, A.C., Li, J., Mehta, S., Sanai, N.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2023 117(2) Supplement:e115-e115
Databáze: ScienceDirect